API

Deca Peptide (6mg)

Drug classification

MHG 6mg Lotion is a dermatological agent; specific subclass: synthetic peptide.

Dosage form

Topical lotion containing 6mg Deca Peptide per specified volume.

API strength per dosage

Dose

Standard dosing for MHG 6mg Lotion (Deca Peptide) is not established in major pharmacological references. Always follow the prescribing information or healthcare provider instructions. Safety and efficacy in paediatric, renal, or hepatic impairment populations have not been established; use with caution and consult a healthcare professional for individualized recommendations.

Mechanism of action

Deca Peptide in MHG 6mg Lotion is a synthetic peptide that stimulates melanogenesis by binding to melanocortin 1 receptors (MC1R) on melanocytes, increasing melanin production. This results in skin darkening or repigmentation, potentially beneficial in conditions like vitiligo or hypopigmentation.

Indications

Vitiligo

Side effects

Dry skin Skin irritation Burning sensation

Pregnancy category

There are insufficient human data on Deca Peptide use in pregnancy; use only if potential benefits justify potential risks to the fetus.

Precautions

Avoid contact with eyes and mucous membranes, discontinue if irritation or hypersensitivity occurs, monitor for local skin reactions, use with caution in patients with known allergies to peptides, not established for use in pregnancy or lactation, safety and efficacy in children not established.

Contraindications

Hypersensitivity to Deca Peptide or any component of the formulation, active skin infections at the application site, open wounds, or known allergy to peptides.